title: Cytotoxic Effect of Arsenic Trioxide in Adenocarcinoma Colorectal Cancer (HT-29) Cells.
abstract: Arsenic is a heavy metal that exhibits a high degree of toxicity to various organ systems. In humans, this compound is associated with an increase risk of skin cancer, and may cause cancers of the lung, liver, bladder, kidney, and colon. The mechanism of arsenic-related carcinogenicity remains to be elucidated. Hence, the aim of the present study was to investigate the cytotoxic effects of arsenic trioxide (As(2)O(3)) on adenocarcinoma colorectal cancer (HT-29) cells using the MTT [3-(4,5 dimethylthiazoyl-2-yl)-2,5- diphenyltetrazolium bromide] assay for cell viability. To achieve this objective, HT-29 cells were cultured and exposed to various doses (0, 2, 4, 6, 8, 10, 12, and 14 μg/ml) of arsenic trioxide for 24 h, 48 h, and 72 h respectively, and subsequently assessed for viability following a standard MTT test protocol. Experimental data indicated that arsenic trioxide is cytotoxic to colon cancer cells showing LD(50) values of 9.8, 9.4 and 9.0 μg/ml upon 24, 48 and 72 h of exposure, respectively. There was a dose-dependent response with regard to As(2)O(3) toxicity in HT-29 cells. Although there was a reduction in LD(50) value with increasing exposure time, this decrease was not statistically significant.
authors: Molecular and Cellular Biology Research Laboratory and Molecular Toxicology Research Laboratory, NIH-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, 1400 JR Lynch Street, Box 18540, Jackson, Mississippi, USA.
authors: Jacqueline J
authors: JJ
authors: Stevens
authors: Barbara
authors: B
authors: Graham-Evans
authors: Alice M
authors: AM
authors: Walker
authors: Brinda
authors: B
authors: Armstead
authors: Paul B
authors: PB
authors: Tchounwou
references: Toxicol Lett. 2002 Jul 7;133(1):1-16
references: 12076506
references: Environ Health Perspect. 1994 Sep;102 Suppl 3:101-5
references: 7843080
references: Environ Health Perspect. 1999 Jul;107(7):593-7
references: 10379007
references: Environ Health Perspect. 2002 Oct;110 Suppl 5:797-9
references: 12426134
references: Mol Cell Biochem. 2007 Jul;301(1-2):123-30
references: 17216127
references: Cancer Res. 2002 Jul 15;62(14):3893-903
references: 12124315
references: Toxicol Pathol. 2003 Nov-Dec;31(6):575-88
references: 14585726
references: J Cell Biochem. 2004 Sep 1;93(1):173-87
references: 15352174
references: Altern Med Rev. 2003 May;8(2):106-28
references: 12777158
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Met Ions Biol Med. 2006;9:298-303
references: 26435679
references: CA Cancer J Clin. 2001 Jul-Aug;51(4):254-62
references: 11577490
references: Environ Health Perspect. 2006 Nov;114(11):1790-6
references: 17107869
references: Clin Cancer Res. 2000 Dec;6(12):4957-64
references: 11156257
references: Environ Health Perspect. 2007 Jul;115(7):A339-40; author reply A340-1
references: 17637893
references: Blood. 1996 Aug 1;88(3):1052-61
references: 8704214